{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T18:52:11Z","timestamp":1779130331146,"version":"3.51.4"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,7,20]],"date-time":"2016-07-20T00:00:00Z","timestamp":1468972800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12885-016-2556-y","type":"journal-article","created":{"date-parts":[[2016,7,20]],"date-time":"2016-07-20T15:01:45Z","timestamp":1469026905000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["NRASQ61K mutated primary leptomeningeal melanoma in a child: case presentation and discussion on clinical and diagnostic implications"],"prefix":"10.1186","volume":"16","author":[{"given":"Giulia","family":"Angelino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Debora","family":"De Pasquale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luigi","family":"De Sio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annalisa","family":"Serra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Massimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rita","family":"De Vito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Marrazzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Lancella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Carai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manila","family":"Antonelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felice","family":"Giangaspero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Gessi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Menchini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Scarciolla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Longo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Mastronuzzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,7,20]]},"reference":[{"key":"2556_CR1","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1111\/j.1750-3639.2003.tb00038.x","volume":"13","author":"A Perry","year":"2003","unstructured":"Perry A, Dehner LP. Meningeal tumors of childhood and infancy. An update and literature review. Brain Pathol. 2003;13:386\u2013408.","journal-title":"Brain Pathol"},{"key":"2556_CR2","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1002\/(SICI)1097-0142(19990901)86:5<878::AID-CNCR26>3.0.CO;2-Y","volume":"86","author":"GW Makin","year":"1999","unstructured":"Makin GW, Eden OB, Lashford LS, Moppett J, Gerrard MP, Davies HA, Powell CV, Campbell AN, Frances H. Leptomeningeal melanoma in childhood. Cancer. 1999;86:878\u201386.","journal-title":"Cancer"},{"key":"2556_CR3","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/0887-8994(94)00155-U","volume":"12","author":"P Nicolaides","year":"1995","unstructured":"Nicolaides P, Newton RW, Kelsey A. Primary malignant melanoma of meninges: atypical presentation of subacute meningitis. Pediatr Neurol. 1995;12:172\u20134.","journal-title":"Pediatr Neurol"},{"key":"2556_CR4","first-page":"325","volume":"45","author":"N Selcuk","year":"2008","unstructured":"Selcuk N, Elevli M, Inanc D, Arslan H. Atypical teratoid\/rhabdoid tumor mimicking tuberculous meningitis. Indian Pediatr. 2008;45:325\u20136.","journal-title":"Indian Pediatr"},{"key":"2556_CR5","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s00381-010-1218-7","volume":"27","author":"HA Demir","year":"2011","unstructured":"Demir HA, Varan A, Aky\u00fcz C, S\u00f6ylemezo\u011flu F, Cila A, B\u00fcy\u00fckpamuk\u00e7u M. Spinal low-grade neoplasm with leptomeningeal dissemination mimicking tuberculous meningitis in a child. Childs Nerv Syst. 2011;27:187\u201392.","journal-title":"Childs Nerv Syst"},{"key":"2556_CR6","doi-asserted-by":"publisher","first-page":"NP171","DOI":"10.1177\/0883073813509121","volume":"29","author":"M Kosker","year":"2014","unstructured":"Kosker M, Sener D, Kilic O, Hasiloglu ZI, Islak C, Kafadar A, Batur S, Oz B, Cokugras H, Akcakaya N, Camcioglu Y. Primary diffuse leptomeningeal gliomatosis mimicking tuberculous meningitis. J Child Neurol. 2014;29:NP171\u20135.","journal-title":"J Child Neurol"},{"key":"2556_CR7","first-page":"127","volume":"33","author":"EB Erdogan","year":"2014","unstructured":"Erdogan EB, Asa S, Yilmaz Aksoy S, Ozhan M, Aliyev A, Halac M. Primary spinal leptomeningeal gliomatosis in a 3-year-old boy revealed with MRI and FDG PET\/CT mimicking tuberculosis meningitis. Rev Esp Med Nucl Imagen Mol. 2014;33:127\u20138.","journal-title":"Rev Esp Med Nucl Imagen Mol"},{"key":"2556_CR8","volume-title":"WHO Classification of Tumours of the Central Nervous System","author":"DJ Brat","year":"2007","unstructured":"Brat DJ, Perry A. Melanocytic lesions. In: Louis DN, Ohgaki H, Weistler OD, Cavenee WK, editors. WHO Classification of Tumours of the Central Nervous System. 4th ed. Lyon: Intl. Agency for Research; 2007.","edition":"4"},{"key":"2556_CR9","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1007\/BF01945262","volume":"16","author":"R Virchow","year":"1859","unstructured":"Virchow R. Pigment und diffuse melanose der arachnoides. Virchows Arch Pathol Anat. 1859;16:180.","journal-title":"Virchows Arch Pathol Anat"},{"key":"2556_CR10","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.50.0264","author":"YY Hsieh","year":"2014","unstructured":"Hsieh YY, Yang ST, Li WH, Hu CJ, Wang LS. Primary Leptomeningeal Melanoma Mimicking Meningitis: A Case Report and Literature Review. J Clin Oncol. 2014. doi:\n                    10.1200\/JCO.2013.50.0264\n                    \n                  .","journal-title":"J Clin Oncol"},{"key":"2556_CR11","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1227\/00006123-199305000-00004","volume":"32","author":"D Allcutt","year":"1993","unstructured":"Allcutt D, Michowiz S, Weitzman S, Becker L, Blaser S, Hoffman HJ, Humphreys RP, Drake JM, Rutka JT. Primary leptomeningeal melanoma: an unusually aggressive tumor in childhood. Neurosurgery. 1993;32:721\u20139.","journal-title":"Neurosurgery"},{"key":"2556_CR12","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1111\/bpa.12241","volume":"25","author":"HV K\u00fcsters-Vandevelde","year":"2015","unstructured":"K\u00fcsters-Vandevelde HV, K\u00fcsters B, van Engen-van Grunsven AC, Groenen PJ, Wesseling P, Blokx WA. Primary melanocytic tumors of the central nervous system: a review with focus on molecular aspects. Brain Pathol. 2015;25:209\u201326.","journal-title":"Brain Pathol"},{"issue":"1","key":"2556_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2350\/14-10-1566-OA.1","volume":"18","author":"CM Salgado","year":"2015","unstructured":"Salgado CM, Basu D, Nikiforova M, Bauer BS, Johnson D, Rundell V, Grunwaldt LJ, Reyes-M\u00fagica M. BRAF mutations are also associated with neurocutaneous melanocytosis and large\/giant congenital melanocytic nevi. Pediatr Dev Pathol. 2015;18(1):1\u20139.","journal-title":"Pediatr Dev Pathol"},{"issue":"4","key":"2556_CR14","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1158\/2159-8290.CD-12-0464","volume":"3","author":"M Pedersen","year":"2013","unstructured":"Pedersen M, K\u00fcsters-Vandevelde HV, Viros A, Groenen PJ, Sanchez-Laorden B, Gilhuis JH, van Engen-van Grunsven IA, Renier W, Schieving J, Niculescu-Duvaz I, Springer CJ, K\u00fcsters B, Wesseling P, Blokx WA, Marais R. Primary melanoma of the CNS in children is driven by congenital expression of oncogenic NRAS in melanocytes. Cancer Discov. 2013;3(4):458\u201369.","journal-title":"Cancer Discov"},{"issue":"9","key":"2556_CR15","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.1038\/jid.2013.70","volume":"133","author":"VA Kinsler","year":"2013","unstructured":"Kinsler VA, Thomas AC, Ishida M, Bulstrode NW, Loughlin S, Hing S, Chalker J, McKenzie K, Abu-Amero S, Slater O, Chanudet E, Palmer R, Morrogh D, Stanier P, Healy E, Sebire NJ, Moore GE. Multiple congenital melanocytic nevi and neurocutaneous melanosis are caused by postzygotic mutations in codon 61 of NRAS. J Invest Dermatol. 2013;133(9):2229\u201336.","journal-title":"J Invest Dermatol"},{"key":"2556_CR16","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/2051-5960-2-41","volume":"2","author":"HV K\u00fcsters-Vandevelde","year":"2014","unstructured":"K\u00fcsters-Vandevelde HV, Willemsen AE, Groenen PJ, K\u00fcsters B, Lammens M, Wesseling P, Djafarihamedani M, Rijntjes J, Delye H, Willemsen MA, van Herpen CM, Blokx WA. Experimental treatment of NRAS-mutated neurocutaneous melanocytosis with MEK162, a MEK-inhibitor. Acta Neuropathol Commun. 2014;2:41.","journal-title":"Acta Neuropathol Commun"},{"issue":"1","key":"2556_CR17","doi-asserted-by":"publisher","first-page":"43","DOI":"10.4161\/cc.23108","volume":"12","author":"C Hafner","year":"2013","unstructured":"Hafner C, Groesser L. Mosaic RASopathies. Cell Cycle. 2013;12(1):43\u201350.","journal-title":"Cell Cycle"},{"key":"2556_CR18","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s40478-014-0140-8","volume":"2","author":"F Shih","year":"2014","unstructured":"Shih F, Yip S, McDonald PJ, Chudley AE, Del Bigio MR. Oncogenic codon 13 NRAS mutation in a primary mesenchymal brain neoplasm and nevus of a child with neurocutaneous melanosis. Acta Neuropathol Commun. 2014;2:140.","journal-title":"Acta Neuropathol Commun"},{"issue":"1","key":"2556_CR19","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/sj.jid.5700490","volume":"127","author":"J Bauer","year":"2007","unstructured":"Bauer J, Curtin JA, Pinkel D, Bastian BC. Congenital melanocytic nevi frequently harbor NRAS mutations but no BRAF mutations. J Invest Dermatol. 2007;127(1):179\u201382.","journal-title":"J Invest Dermatol"},{"issue":"21","key":"2556_CR20","doi-asserted-by":"publisher","first-page":"2822","DOI":"10.1101\/gad.11.21.2822","volume":"11","author":"L Chin","year":"1997","unstructured":"Chin L, Pomerantz J, Polsky D, Jacobson M, Cohen C, Cordon-Cardo C, Horner 2nd JW, DePinho RA. Cooperative effects of INK4a and ras in melanoma susceptibility in vivo. Genes Dev. 1997;11(21):2822\u201334.","journal-title":"Genes Dev"},{"issue":"10","key":"2556_CR21","doi-asserted-by":"publisher","first-page":"4005","DOI":"10.1158\/0008-5472.CAN-04-2970","volume":"65","author":"J Ackermann","year":"2005","unstructured":"Ackermann J, Frutschi M, Kaloulis K, McKee T, Trumpp A, Beermann F. Metastasizing melanoma formation caused by expression of activated N-RasQ61K on an INK4a-deficient background. Cancer Res. 2005;65(10):4005\u201311.","journal-title":"Cancer Res"},{"issue":"5","key":"2556_CR22","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1148\/rg.295095109","volume":"29","author":"AB Smith","year":"2009","unstructured":"Smith AB, Rushing EJ, Smirniotopoulos JG. Pigmented lesions of the central nervous system: radiologic-pathologic correlation. Radiographics. 2009;29(5):1503\u201324.","journal-title":"Radiographics"},{"issue":"2","key":"2556_CR23","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/S0344-0338(11)80709-0","volume":"190","author":"Y Nagashima","year":"1994","unstructured":"Nagashima Y, Miyagi Y, Aoki I, Funabiki T, Ikuta K, Umeda M, Kuchino Y, Misugi K. Establishment and characterization of a malignant melanoma cell line (YP-MEL) derived from a patient with neurocutaneous melanosis. Pathol Res Pract. 1994;190(2):178\u201385.","journal-title":"Pathol Res Pract"},{"issue":"2","key":"2556_CR24","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1097\/PPO.0b013e31824ba4df","volume":"18","author":"FC Kelleher","year":"2012","unstructured":"Kelleher FC, McArthur GA. Targeting NRAS in melanoma. Cancer J. 2012;18(2):132\u20136.","journal-title":"Cancer J"},{"key":"2556_CR25","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/1476-4598-11-22","volume":"11","author":"E Euw von","year":"2012","unstructured":"von Euw E, Atefi M, Attar N, Chu C, Zachariah S, Burgess BL, Mok S, Ng C, Wong DJ, Chmielowski B, Lichter DI, Koya RC, McCannel TA, Izmailova E, Ribas A. Antitumor effects of the investigational selective MEK inhibitor TAK733 against cutaneous and uveal melanoma cell lines. Mol Cancer. 2012;11:22.","journal-title":"Mol Cancer"},{"issue":"3","key":"2556_CR26","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/S1470-2045(13)70024-X","volume":"14","author":"PA Ascierto","year":"2013","unstructured":"Ascierto PA, Schadendorf D, Berking C, Agarwala SS, van Herpen CM, Queirolo P, Blank CU, Hauschild A, Beck JT, St-Pierre A, Niazi F, Wandel S, Peters M, Zubel A, Dummer R. MEK162 for patients with advanced melanoma harbouring NRAS or Val600 BRAF mutations: a non-randomised, open-label phase 2 study. Lancet Oncol. 2013;14(3):249\u201356.","journal-title":"Lancet Oncol"},{"issue":"6","key":"2556_CR27","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1093\/neuonc\/nou310","volume":"17","author":"Y Ruan","year":"2015","unstructured":"Ruan Y, Kovalchuk A, Jayanthan A, Lun X, Nagashima Y, Kovalchuk O, Wright Jr JR, Pinto A, Kirton A, Anderson R, Narendran A. Druggable targets in pediatric neurocutaneous melanocytosis: Molecular and drug sensitivity studies in xenograft and ex vivo tumor cell culture to identify agents for therapy. Neuro Oncol. 2015;17(6):822\u201331.","journal-title":"Neuro Oncol"},{"issue":"19","key":"2556_CR28","doi-asserted-by":"publisher","first-page":"5290","DOI":"10.1158\/1078-0432.CCR-12-0563","volume":"18","author":"PJ Roberts","year":"2012","unstructured":"Roberts PJ, Usary JE, Darr DB, Dillon PM, Pfefferle AD, Whittle MC, Duncan JS, Johnson SM, Combest AJ, Jin J, Zamboni WC, Johnson GL, Perou CM, Sharpless NE. Combined PI3K\/mTOR and MEK inhibition provides broad antitumor activity in faithful murine cancer models. Clin Cancer Res. 2012;18(19):5290\u2013303.","journal-title":"Clin Cancer Res"},{"issue":"6","key":"2556_CR29","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1111\/pcmr.12303","volume":"27","author":"VW Rebecca","year":"2014","unstructured":"Rebecca VW, Alicea GM, Paraiso KH, Lawrence H, Gibney GT, Smalley KS. Vertical inhibition of the MAPK pathway enhances therapeutic responses in NRAS-mutant melanoma. Pigment Cell Melanoma Res. 2014;27(6):1154\u20138.","journal-title":"Pigment Cell Melanoma Res"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-016-2556-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-016-2556-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-016-2556-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-016-2556-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,2,22]],"date-time":"2017-02-22T14:52:36Z","timestamp":1487775156000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-016-2556-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,20]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["2556"],"URL":"https:\/\/doi.org\/10.1186\/s12885-016-2556-y","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,20]]},"article-number":"512"}}